Neuroscience

SARS-CoV-2 vaccine does not increase new-onset seizure risk

There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus placebo, according to a review published online April 29 in JAMA Neurology.

Diseases, Conditions, Syndromes

Specific nasal cells found to protect against COVID-19 in children

Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, finds a new study led by researchers at UCL ...

page 3 from 40